Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität LeipzigLeipzig, Germany; Center for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany.
Division of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University Utrecht, Netherlands.
Front Cell Dev Biol. 2016 May 10;4:39. doi: 10.3389/fcell.2016.00039. eCollection 2016.
The Gram-negative bacterium Pseudomonas aeruginosa is a life-threatening nosocomial pathogen due to its generally low susceptibility toward antibiotics. Furthermore, many strains have acquired resistance mechanisms requiring new antimicrobials with novel mechanisms to enhance treatment options. Proline-rich antimicrobial peptides, such as the apidaecin analog Api137, are highly efficient against various Enterobacteriaceae infections in mice, but less active against P. aeruginosa in vitro. Here, we extended our recent work by optimizing lead peptides Api755 (gu-OIORPVYOPRPRPPHPRL-OH; gu = N,N,N',N'-tetramethylguanidino, O = L-ornithine) and Api760 (gu-OWORPVYOPRPRPPHPRL-OH) by incorporation of Ile-Orn- and Trp-Orn-motifs, respectively. Api795 (gu-O(IO)2RPVYOPRPRPPHPRL-OH) and Api794 (gu-O(WO)3RPVYOPRPRPPHPRL-OH) were highly active against P. aeruginosa with minimal inhibitory concentrations of 8-16 and 8-32 μg/mL against Escherichia coli and Klebsiella pneumoniae. Assessed using a quartz crystal microbalance, these peptides inserted into a membrane layer and the surface activity increased gradually from Api137, over Api795, to Api794. This mode of action was confirmed by transmission electron microscopy indicating some membrane damage only at the high peptide concentrations. Api794 and Api795 were highly stable against serum proteases (half-life times >5 h) and non-hemolytic to human erythrocytes at peptide concentrations of 0.6 g/L. At this concentration, Api795 reduced the cell viability of HeLa cells only slightly, whereas the IC50 of Api794 was 0.23 ± 0.09 g/L. Confocal fluorescence microscopy revealed no colocalization of 5(6)-carboxyfluorescein-labeled Api794 or Api795 with the mitochondria, excluding interactions with the mitochondrial membrane. Interestingly, Api795 was localized in endosomes, whereas Api794 was present in endosomes and the cytosol. This was verified using flow cytometry showing a 50% higher uptake of Api794 in HeLa cells compared with Api795. The uptake was reduced for both peptides by 50 and 80%, respectively, after inhibiting endocytotic uptake with dynasore. In summary, Api794 and Api795 were highly active against P. aeruginosa in vitro. Both peptides passed across the bacterial membrane efficiently, most likely then disturbing the ribosome assembly, and resulting in further intracellular damage. Api795 with its IOIO-motif, which was particularly active and only slightly toxic in vitro, appears to represent a promising third generation lead compound for the development of novel antibiotics against P. aeruginosa.
铜绿假单胞菌是一种具有生命威胁的医院获得性病原体,因为其对抗生素的普遍低敏感性。此外,许多菌株已经获得了需要具有新机制的新型抗菌药物的耐药机制,以增强治疗选择。富含脯氨酸的抗菌肽,如蜂毒素类似物 Api137,在小鼠中对各种肠杆菌科感染具有高度的功效,但在体外对铜绿假单胞菌的活性较低。在这里,我们通过分别掺入 Ile-Orn-和 Trp-Orn 基序来扩展我们最近的工作,优化了先导肽 Api755(gu-OIORPVYOPRPRPPHPRL-OH;gu = N,N,N',N'-四甲基胍基,O = L-鸟氨酸)和 Api760(gu-OWORPVYOPRPRPPHPRL-OH)。Api795(gu-O(IO)2RPVYOPRPRPPHPRL-OH)和 Api794(gu-O(WO)3RPVYOPRPRPPHPRL-OH)对铜绿假单胞菌具有高度活性,最小抑菌浓度分别为 8-16 和 8-32μg/ml,对大肠杆菌和肺炎克雷伯菌也有活性。使用石英晶体微天平评估,这些肽插入到膜层中,表面活性从 Api137逐渐增加,到 Api795 再到 Api794。透射电子显微镜证实了这种作用模式,仅在高肽浓度下才显示出一些膜损伤。Api794 和 Api795 对血清蛋白酶具有高度稳定性(半衰期 >5 小时),在肽浓度为 0.6g/L 时对人红细胞无溶血作用。在该浓度下,Api795 仅略微降低 HeLa 细胞的细胞活力,而 Api794 的 IC50 为 0.23±0.09g/L。共聚焦荧光显微镜显示,5(6)-羧基荧光素标记的 Api794 或 Api795 与线粒体无共定位,排除了与线粒体膜的相互作用。有趣的是,Api795 定位于内体中,而 Api794 存在于内体和细胞质中。这通过流式细胞术得到证实,显示出与 Api795 相比,Api794 在 HeLa 细胞中的摄取率高 50%。在用 dynasore 抑制内吞作用后,两种肽的摄取率分别降低了 50%和 80%。总之,Api794 和 Api795 在体外对铜绿假单胞菌具有高度活性。两种肽都能有效地穿过细菌膜,很可能随后干扰核糖体组装,并导致进一步的细胞内损伤。Api795 具有 IOIO 基序,其在体外特别有效且毒性较低,似乎代表了开发针对铜绿假单胞菌的新型抗生素的有前途的第三代先导化合物。